AMRS News 4.37 08/28/2014 04:33:31 Amyris Inc (AMRS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amyris Inc (AMRS) 4.37 $AMRS

Can Amyris (AMRS) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 7:54AM CDT
Amyris has been witnessing positive trend in earnings estimate front and possess a favorable Zacks Rank

Amyris (AMRS) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 7:31AM CDT
Amyris (AMRS) Shares March Higher, Can It Continue?

5 Stocks Triggering Big Breakout Trades
at The Street - Mon Aug 18, 10:12AM CDT
These stocks look poised to break out and trade higher from current levels.

How Biofuels and The Boeing Company Are Reshaping the Global Aviation Industry
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Aug 17, 3:26PM CDT
This Boeing 737 will likely takeoff with biofuels before the end of the decade. Source: The Motley Fool/ Flickr . What comes to mind when you think of the airline industry? Perhaps you think about the positives, such as the 3.1 billion passengers...

4 Under-$10 Stocks Making Big Moves
at The Street - Fri Aug 15, 5:00AM CDT
Stocks that are making large moves are favorites among short-term traders because they can jump in and try to capture some of that massive volatility.

Amyris Reports Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:44PM CDT
-- End of quarter cash, cash equivalents and short-term investments balance of $90.2 million.

First International Commercial Flight Completed With Newly Approved Amyris-Total Aviation Biofuel
GlobeNewswire - Thu Jul 31, 12:52PM CDT
Yesterday, Amyris (Nasdaq:AMRS), an industrial bioscience company, partnered with Brazilian airline, GOL, to fly the industry's first commercial flight with farnesane, the recently approved renewable jet fuel. The first flight, GOL flight 7725, departed from Orlando, Florida on July 30, 2014 at 5:15 PM ET and traveled to Sao Paulo, Brazil.

Global Synthetic Biology Market 2014-2018
M2 - Mon Jul 28, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4xp9d8/global_synthetic) has announced the addition of the "Global Synthetic Biology Market 2014-2018" report to their offering. The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment. The analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018. The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Technology 08. Market Segmentation by Product 09. Market Segmentation by Applications 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - Amyris Inc. - E. I. du Pont de Nemours and Co. - Thermo Fisher Scientific Inc. - Synthetic Genomics Inc. - Algenol Biofuels Inc. - ATG:biosynthetics GmbH - Bayer AG - Bioneer Corp. - Biosearch Technologies Inc. - Bristol-Myers Squibb Co. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - Evolva Holdings SA - Exxon Mobil Corp. - GeneWorks Pty Ltd. - Genomatica Inc. - Gevo Inc. - Ginkgo Bioworks - Green Biologics Ltd. - New England Biolabs Inc. - OriGene Technologies Inc. - REG Life Sciences LLC - Royal DSM - Synthorx Inc. For more information visit http://www.researchandmarkets.com/research/4x..._synthetic

Commit To Purchase Amyris At $2.50, Earn 15.3% Annualized Using Options
StockOptionsChannel.com - Fri Jul 25, 10:29AM CDT
Investors eyeing a purchase of Amyris, Inc. shares, but cautious about paying the going market price of $3.63/share, might benefit from considering selling puts among the alternative strategies at their disposal.

4 Cash-Strapped Companies on Life Support - Investment Ideas
Todd Bunton - ZACKS - Thu Jul 24, 5:15PM CDT
4 Cash-Strapped Companies on Life Support - Investment Ideas

Amyris to Announce Second Quarter Financial Results on Thursday, August 7, 2014
GlobeNewswire - Thu Jul 17, 7:17AM CDT
Amyris, Inc. (Nasdaq:AMRS) will report financial results for the second quarter ended June 30, 2014 after market close on Thursday, August 7, 2014.

Brazilian Airline GOL to Make First International Commercial Flights With Newly Approved Amyris-Total Aviation Biofuel
GlobeNewswire - Wed Jul 09, 7:00AM CDT
Amyris (Nasdaq:AMRS) has partnered with Brazilian airline GOL (NYSE:GOL) to begin the first commercial route with farnesane, the recently approved renewable jet fuel.

Should Amyris Investors Fear Intrexon's Farnesene?
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Jul 07, 1:09PM CDT
When a company commercializes a building-block molecule with dozens, if not hundreds, of potential commercial uses, competition is bound to arrive sooner or later. When it comes to farnesene production, that competition may show up sooner than ...

What's the Value of Amyris' Molecule Development Strategy?
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Jun 18, 11:50AM CDT
Artemisinin-based combination therapies are some of the most important weapons wielded by the developing world against malaria, which claims over 620,000 lives each year. While artemisinin is effective, its supply and cost is greatly affected by...

2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019
M2 - Wed Jun 18, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9bcz55/synthetic_biology) has announced the addition of the "2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019" report to their offering. Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. While enabling products are segmented into DNA and oligonucleotide synthesis products. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Synthetic Biology Market, by Products Chapter 5 Global Synthetic Biology Market, by Technologies Chapter 6 Global Synthetic Biology Market, by Applications Chapter 7 Global Synthetic Biology Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned: - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/9b...ic_biology

Amyris Up 5.2%, Shares Break Through Resistance (AMRS)
Comtex SmarTrend(R) - Tue Jun 17, 11:39AM CDT
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 5.2% to $3.85 on 1.2x average daily volume. Thus far today, Amyris has traded 326,000 shares, vs. average volume of 269,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's 0.1%) and outperformed the S&P 500 (5.2% to the S&P's 0.1%) during today's trading.

Total and Amyris Renewable Jet Fuel Ready for Use in Commercial Aviation
GlobeNewswire - Mon Jun 16, 6:55AM CDT
With the newly revised ASTM standard for jet fuel, Amyris (Nasdaq:AMRS) and Total (CAC:TOTF.PA) today begin to prepare to market a drop-in jet fuel that contains up to 10% blends of renewable farnesane.

A Warning for Biofuel Investors
Shamus Funk, The Motley Fool - Motley Fool - Thu Jun 12, 9:57AM CDT
It's hard to believe a company producing and selling shark liver oil and low-friction tire rubber could be telling a story that we've already heard before, but Amyris ' tale is one not unseen in the bio-product industry. Like a poorly written...

4 Stocks Under $10 Making Big Moves
at The Street - Wed Apr 02, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 71

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 89

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 110

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 77

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 226

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 112

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 115

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Feeding America Urges Collaboration to Combat Hunger Crisis

Updated Category News Views 148

Feeding America's Call to Action Against Hunger As food insecurity continues to rise, people across the nation who are struggling with hunger are urging us to unite and take meaningful steps to tackle this critical issue. Recent data indicates a troubling 6% increase in food insecurity over the past year, highlighting the immediate need for a collective response. Even...

Continue Reading
Aviat Networks Announces Participation in Key Investor Events

Updated Category News Views 136

Exciting Investor Conferences Ahead for Aviat Networks Aviat Networks, Inc. (NASDAQ: AVNW), a prominent player in the realm of wireless transport and access solutions, has recently unveiled its participation in some significant upcoming investor conferences. These conferences are an excellent opportunity for investors to engage with the company and learn more about its...

Continue Reading
Berkshire Hathaway Secures $1.9B with Major Samurai Bond Sale

Updated Category News Views 277

Berkshire Hathaway's Significant Samurai Bond Offering Berkshire Hathaway (NYSE: BRK) has successfully concluded a major bond offering, securing 281.8 billion yen, which is approximately $1.9 billion. This achievement marks the company's largest Samurai bond sale in five years, reflecting its strategic intent to deepen its investment footprint in the Japanese market. The...

Continue Reading
Top 10 Trading Mistakes to Avoid for Successful Investing

Updated Category News Views 150

The Costly Errors in Trading Many traders stumble not due to a lack of opportunities, but because they inadvertently make damaging decisions. It's crucial to recognize that the line between success and failure often lies in avoiding habits that negatively impact your trading account. In this article, we will delve into the 10 most detrimental trading mistakes....

Continue Reading
DEWALT POWERSHIFT™: Revolutionizing Electric Tools for Future Jobsites

Updated Category News Views 344

DEWALT POWERSHIFT™: A Leap Towards Sustainability DEWALT, a distinguished name in construction tools, has just introduced the DEWALT POWERSHIFT™ Cordless Equipment System, a groundbreaking series of tools designed to transform the future of jobsites. This innovative system significantly reduces environmental impact, boasting a remarkable capability to produce up to...

Continue Reading